These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8764567)

  • 1. Loss of autoantibody activity by alteration in autoantigen.
    Spitzer RE; Stitzel AE
    Clin Immunol Immunopathol; 1996 Aug; 80(2):211-3. PubMed ID: 8764567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).
    Ohi H; Yasugi T
    Clin Exp Immunol; 1994 Feb; 95(2):316-21. PubMed ID: 8306508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.
    Tanuma Y; Ohi H; Hatano M
    Clin Immunol Immunopathol; 1990 Aug; 56(2):226-38. PubMed ID: 2143128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M; Balow JE; Tsokos GC
    J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human anti-idiotypic antibody responses to autoantibody against the alternative pathway C3 convertase.
    Spitzer RE; Stitzel AE; Tsokos GC
    Clin Immunol Immunopathol; 1990 Oct; 57(1):19-31. PubMed ID: 2394034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy.
    Garam N; Prohászka Z; Szilágyi Á; Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G; Bajcsi D; Brunner J; Dumfarth A; Cejka D; Flaschberger S; Flögelova H; Haris Á; Hartmann Á; Heilos A; Mueller T; Rusai K; Arbeiter K; Hofer J; Jakab D; Sinkó M; Szigeti E; Bereczki C; Janko V; Kelen K; Reusz GS; Szabó AJ; Klenk N; Kóbor K; Kojc N; Knechtelsdorfer M; Laganovic M; Lungu AC; Meglic A; Rus R; Kersnik-Levart T; Macioniene E; Miglinas M; Pawłowska A; Stompór T; Podracka L; Rudnicki M; Mayer G; Romana Rysava ; Reiterova J; Saraga M; Tomáš Seeman ; Zieg J; Sládková E; Szabó T; Capitanescu A; Stancu S; Tisljar M; Galesic K; Tislér A; Vainumäe I; Windpessl M; Zaoral T; Zlatanova G; Csuka D
    Orphanet J Rare Dis; 2019 Nov; 14(1):247. PubMed ID: 31703608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN).
    Ohi H; Watanabe S; Fujita T; Yasugi T
    Clin Exp Immunol; 1992 Sep; 89(3):479-84. PubMed ID: 1516262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of C3bBb-stabilizing activity (C3 nephritic factor) in the serum from patients with membranoproliferative glomerulonephritis.
    Ohi H; Watanabe S; Fujita T; Seki M; Hatano M
    J Immunol Methods; 1990 Jul; 131(1):71-6. PubMed ID: 2380570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.
    Strife CF; Prada AL; Clardy CW; Jackson E; Forristal J
    J Pediatr; 1990 May; 116(5):S98-102. PubMed ID: 2329415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event.
    Spitzer RE; Stitzel AE; Tsokos GC
    J Pediatr; 1990 May; 116(5):S103-8. PubMed ID: 2329411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of IgG and IgM autoantibody to the alternative pathway C3 convertase in normal individuals and patients with membranoproliferative glomerulonephritis.
    Spitzer RE; Stitzel AE; Tsokos GC
    Clin Immunol Immunopathol; 1990 Oct; 57(1):10-8. PubMed ID: 1697516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
    Michels MAHM; van de Kar NCAJ; van Kraaij SAW; Sarlea SA; Gracchi V; Engels FAPT; Dorresteijn EM; van der Deure J; Duineveld C; Wetzels JFM; van den Heuvel LPWJ; Volokhina EB
    Front Immunol; 2021; 12():715704. PubMed ID: 34456924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human polyclonal and monoclonal IgG and IgM complement 3 nephritic factors: evidence for idiotypic commonality.
    Tsokos GC; Stitzel AE; Patel AD; Hiramatsu M; Balow JE; Spitzer RE
    Clin Immunol Immunopathol; 1989 Oct; 53(1):113-22. PubMed ID: 2475285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor H autoantibodies in membranoproliferative glomerulonephritis.
    Goodship TH; Pappworth IY; Toth T; Denton M; Houlberg K; McCormick F; Warland D; Moore I; Hunze EM; Staniforth SJ; Hayes C; Cavalcante DP; Kavanagh D; Strain L; Herbert AP; Schmidt CQ; Barlow PN; Harris CL; Marchbank KJ
    Mol Immunol; 2012 Oct; 52(3-4):200-6. PubMed ID: 22721707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide sequence of a human autoantibody to the alternative pathway C3/C5 convertase (C3NeF).
    Victor KD; Pascual V; Stitzel AE; Tsokos GC; Capra JD; Spitzer RE
    Hybridoma; 1993 Jun; 12(3):231-7. PubMed ID: 8395463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.